227 related articles for article (PubMed ID: 8101355)
1. Design, synthesis and biological activity of protaxols.
Nicolaou KC; Riemer C; Kerr MA; Rideout D; Wrasidlo W
Nature; 1993 Jul; 364(6436):464-6. PubMed ID: 8101355
[TBL] [Abstract][Full Text] [Related]
2. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
3. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
4. Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams JD; Flora KP; Goldspiel BR; Wilson JW; Arbuck SG; Finley R
J Natl Cancer Inst Monogr; 1993; (15):141-7. PubMed ID: 7912520
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
Kingston DG; Chaudhary AG; Chordia MD; Gharpure M; Gunatilaka AA; Higgs PI; Rimoldi JM; Samala L; Jagtap PG; Giannakakou P; Jiang YQ; Lin CM; Hamel E; Long BH; Fairchild CR; Johnston KA
J Med Chem; 1998 Sep; 41(19):3715-26. PubMed ID: 9733497
[TBL] [Abstract][Full Text] [Related]
6. [Synthesis and structure-activity relationships of novel 14 beta-side chain taxol derivatives].
Liu R; Yin D; Wang D; Li C; Guo J; Liang X
Yao Xue Xue Bao; 1998 Dec; 33(12):910-8. PubMed ID: 12016856
[TBL] [Abstract][Full Text] [Related]
7. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of taxol.
Nicolaou KC; Yang Z; Liu JJ; Ueno H; Nantermet PG; Guy RK; Claiborne CF; Renaud J; Couladouros EA; Paulvannan K
Nature; 1994 Feb; 367(6464):630-4. PubMed ID: 7906395
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity.
Burkhart CA; Berman JW; Swindell CS; Horwitz SB
Cancer Res; 1994 Nov; 54(22):5779-82. PubMed ID: 7954398
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel analogues of dictyostatin.
Paterson I; Gardner NM; Poullennec KG; Wright AE
Bioorg Med Chem Lett; 2007 May; 17(9):2443-7. PubMed ID: 17336522
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity study on the actions of taxol and related taxanes on primary cultures of adrenal medullary cells.
McKay DB
J Pharmacol Exp Ther; 1989 Mar; 248(3):1302-7. PubMed ID: 2564892
[TBL] [Abstract][Full Text] [Related]
12. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
13. Modulating paclitaxel bioavailability for targeting prostate cancer.
Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR
Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer.
Liu C; Strobl JS; Bane S; Schilling JK; McCracken M; Chatterjee SK; Rahim-Bata R; Kingston DG
J Nat Prod; 2004 Feb; 67(2):152-9. PubMed ID: 14987051
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and in vitro cytotoxicity studies of a macromolecular conjugate of paclitaxel bearing oxytocin as targeting moiety.
Cavallaro G; Maniscalco L; Campisi M; Schillaci D; Giammona G
Eur J Pharm Biopharm; 2007 May; 66(2):182-92. PubMed ID: 17182230
[TBL] [Abstract][Full Text] [Related]
16. Butitaxel analogues: synthesis and structure-activity relationships.
Ali SM; Hoemann MZ; Aubé J; Georg GI; Mitscher LA; Jayasinghe LR
J Med Chem; 1997 Jan; 40(2):236-41. PubMed ID: 9003522
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard.
Lougerstay-Madec R; Florent JC; Monneret C; Nemati F; Poupon MF
Anticancer Drug Des; 1998 Dec; 13(8):995-1007. PubMed ID: 10335272
[TBL] [Abstract][Full Text] [Related]
18. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.
Zhao RY; Erickson HK; Leece BA; Reid EE; Goldmacher VS; Lambert JM; Chari RV
J Med Chem; 2012 Jan; 55(2):766-82. PubMed ID: 22148292
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
